Worsening HF Episodes Outside a Hospital Setting in Heart Failure with Preserved Ejection Fraction: the PARAGON-HF Trial

被引:0
|
作者
Vaduganathan, M. Muthiah [1 ]
Claggett, B. L. [1 ]
Mccausland, F. [1 ]
Barkoudah, E. [1 ]
Finn, P. [1 ]
Cunningham, J. [1 ]
Zannad, F. [2 ]
Pfeffer, M. [1 ]
Rizkala, A. [3 ]
Sabarwal, S. [3 ]
Mcmurray, J. J. V. [4 ]
Solomon, S. D. [1 ]
Desai, A. S. [1 ]
机构
[1] Brigham & Womens Hosp, Heart & Vasc Ctr, 75 Francis St, Boston, MA 02115 USA
[2] Univ Lorraine, Nancy, France
[3] Novartis, E Hanover, NJ USA
[4] Univ Glasgow, Glasgow, Lanark, Scotland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
94
引用
收藏
页码:11 / 12
页数:2
相关论文
共 50 条
  • [41] Serum uric acid, influence of sacubitril/valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction: PARAGON-HF
    Selvaraj, S.
    Claggett, B. L.
    Veldhuisen, D. V.
    Anand, I. S.
    Pieske, B.
    Rouleau, J. L.
    Zile, M. R.
    Shi, V. C.
    Lelkowite, M. P.
    McMurray, J. J., V
    Solomon, S. D.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1066 - 1066
  • [42] Effect of Sacubitril/Valsartan on Cognitive Function in Patients With Heart Failure With Preserved Ejection Fraction: A Prespecified Analysis of PARAGON-HF
    Dewan, Pooja
    Shen, Li
    Ferreira, Joao Pedro
    Jhund, Pardeep S.
    Anand, Inder S.
    Chandra, Alvin
    Chiang, Lu-May
    Claggett, Brian
    Desai, Akshay S.
    Gong, Jianjian
    Lam, Carolyn S. P.
    Lefkowitz, Martin P.
    Maggioni, Aldo P.
    Martinez, Felipe
    Packer, Milton
    Redfield, Margaret M.
    Rouleau, Jean L.
    van Veldhuisen, Dirk J.
    Zannad, Faiez
    Zile, Michael R.
    Solomon, Scott D.
    McMurray, John J. V.
    CIRCULATION, 2024, 150 (04) : 272 - 282
  • [43] Serum uric acid, influence of sacubitril-valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction:PARAGON-HF
    Selvaraj, Senthil
    Claggett, Brian L.
    Pfeffer, Marc A.
    Desai, Akshay S.
    Mc Causland, Finnian R.
    McGrath, Martina M.
    Anand, Inder S.
    van Veldhuisen, Dirk J.
    Kober, Lars
    Janssens, Stefan
    Cleland, John G. F.
    Pieske, Burkert
    Rouleau, Jean L.
    Zile, Michael R.
    Shi, Victor C.
    Lefkowitz, Martin P.
    McMurray, John J. V.
    Solomon, Scott D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (11) : 2093 - 2101
  • [44] Natriuretic peptide-based inclusion criteria in heart failure with preserved ejection fraction clinical trials: insights from PARAGON-HF
    Pabon, Maria A.
    Cunningham, Jonathan W.
    Claggett, Brian L.
    Packer, Milton
    Zile, Michael
    Pfeffer, Marc A.
    Lefkowitz, Martin
    Shi, Victor
    Rizkala, Adel
    McMurray, John J., V
    Solomon, Scott D.
    Vaduganathan, Muthiah
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (04) : 672 - 677
  • [45] Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction Insights From PARAGON-HF
    McMurray, John J., V
    Jackson, Alice M.
    Lam, Carolyn S. P.
    Redfield, Margaret M.
    Anand, Inder S.
    Ge, Junbo
    Lefkowitz, Marty P.
    Maggioni, Aldo P.
    Martinez, Felipe
    Packer, Milton
    Pfeffer, Marc A.
    Pieske, Burkert
    Rizkala, Adel R.
    Sabarwal, Shalini, V
    Shah, Amil M.
    Shah, Sanjiv J.
    Shi, Victor C.
    van Veldhuisen, Dirk J.
    Zannad, Faiez
    Zile, Michael R.
    Cikes, Maja
    Goncalvesova, Eva
    Katova, Tzvetana
    Kosztin, Anamaria
    Lelonek, Malgorzata
    Sweitzer, Nancy
    Vardeny, Orly
    Claggett, Brian
    Jhund, Pardeep S.
    Solomon, Scott D.
    CIRCULATION, 2020, 141 (05) : 338 - 351
  • [46] MODE OF DEATH IN PATIENTS WITH HEART FAILURE AND LEFT VENTRICULAR EJECTION FRACTION≥45%: INSIGHTS FROM PARAGON-HF
    Desai, Akshay S.
    Cleland, John
    Vaduganathan, Muthiah
    Claggett, Brian
    Barkoudah, Ebrahim
    Finn, Peter V.
    McCausland, Finnian
    Yilmaz, Mehmet B.
    Lefkowitz, Martin
    Shi, Victor
    Pfeffer, Marc A.
    McMurray, John
    Solomon, Scott D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 998 - 998
  • [47] EFFECTS OF SACUBITRIL/VALSARTAN VERSUS VALSARTAN ON RENAL FUNCTION IN PATIENTS WITH TYPE 2 DIABETES AND HEART FAILURE WITH PRESERVED EJECTION FRACTION: PARAGON-HF
    Peikert, Alexander
    Vaduganathan, Muthiah
    McCausland, Finnian
    Claggett, Brian
    Chatur, Safia
    Packer, Milton
    Pfeffer, Marc A.
    Zannad, Faiez
    Lefkowitz, Martin
    Pieske, Burkert Mathias
    Dungen, Hans-Dirk
    McMurray, John J. V.
    Solomon, Scott D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 308 - 308
  • [48] Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF
    Vaduganathan, Muthiah
    Mentz, Robert J.
    Claggett, Brian L.
    Miao, Zi Michael
    Kulac, Ian J.
    Ward, Jonathan H.
    Hernandez, Adrian F.
    Morrow, David A.
    Starling, Randall C.
    Velazquez, Eric J.
    Williamson, Kristin M.
    Desai, Akshay S.
    Zieroth, Shelley
    Lefkowitz, Martin
    McMurray, John J., V
    Braunwald, Eugene
    Solomon, Scott D.
    EUROPEAN HEART JOURNAL, 2023, 44 (31) : 2982 - 2993
  • [49] PARAGON-HF Clinical Trial Eligibility in a Population of Patients Hospitalized With Heart Failure
    Sayeed, Sabina
    Fudim, Marat
    Devore, Adam D.
    Xu, Haolin
    Matsouaka, Roland A.
    Heidenreich, Paul A.
    Yancy, Clyde W.
    Fonarow, Gregg C.
    Hernandez, Adrian F.
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (12) : 1009 - 1011
  • [50] Effects of sacubitril/valsartan versus valsartan on renal function in patients with and without diabetes and heart failure with preserved ejection fraction: insights from PARAGON-HF
    Peikert, Alexander
    Vaduganathan, Muthiah
    Mc Causland, Finnian
    Claggett, Brian L.
    Chatur, Safia
    Packer, Milton
    Pfeffer, Marc A.
    Zannad, Faiez
    Lefkowitz, Martin P.
    Pieske, Burkert
    Duengen, Hans-Dirk
    McMurray, John J. V.
    Solomon, Scott D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (05) : 794 - 803